免费获得国外相关药品，最快 1 个工作日回馈药物信息
出境医 / 临床实验 / Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation Therapy
Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation Therapy
Study Description
Brief Summary:
the study aim to evaluate the prevalence of cerebral remote microhaemorrhages (RMH) and remote haematomas (RH) using magnetic resonance susceptibility-weighted imaging (SWI) among patients treated for gliomas during follow-up.
| Condition or disease | Intervention/treatment |
|---|---|
| Glioma | Diagnostic Test: Cere |
Study Design
| Study Type : | Observational |
| Actual Enrollment : | 58 participants |
| Observational Model: | Cohort |
| Time Perspective: | Retrospective |
| Official Title: | Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation Therapy |
| Actual Study Start Date : | January 2015 |
| Actual Primary Completion Date : | January 2016 |
| Actual Study Completion Date : | January 2016 |
Arms and Interventions
Outcome Measures
Primary Outcome Measures :
- number of microhaemorrhages (RMH) on magnetic resonance imaging [ Time Frame: one year ]
- number of remote haematomas (RH) on magnetic resonance imaging [ Time Frame: one year ]
Eligibility Criteria
Contacts and Locations
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Submitted Date | May 31, 2019 | ||||
| First Posted Date | June 4, 2019 | ||||
| Last Update Posted Date | June 4, 2019 | ||||
| Actual Study Start Date | January 2015 | ||||
| Actual Primary Completion Date | January 2016 (Final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures |
|
||||
| Original Primary Outcome Measures | Same as current | ||||
| Change History | No Changes Posted | ||||
| Current Secondary Outcome Measures | Not Provided | ||||
| Original Secondary Outcome Measures | Not Provided | ||||
| Current Other Pre-specified Outcome Measures | Not Provided | ||||
| Original Other Pre-specified Outcome Measures | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title | Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation Therapy | ||||
| Official Title | Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation Therapy | ||||
| Brief Summary | the study aim to evaluate the prevalence of cerebral remote microhaemorrhages (RMH) and remote haematomas (RH) using magnetic resonance susceptibility-weighted imaging (SWI) among patients treated for gliomas during follow-up. | ||||
| Detailed Description | Not Provided | ||||
| Study Type | Observational | ||||
| Study Design | Observational Model: Cohort Time Perspective: Retrospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | patients with glioma and folllow up with magnetic resonance imaging | ||||
| Condition | Glioma | ||||
| Intervention | Diagnostic Test: Cere
Magnetic Rseonance imaging for brain tumour follow-up
|
||||
| Study Groups/Cohorts | Not Provided | ||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status | Completed | ||||
| Actual Enrollment |
58 | ||||
| Original Actual Enrollment | Same as current | ||||
| Actual Study Completion Date | January 2016 | ||||
| Actual Primary Completion Date | January 2016 (Final data collection date for primary outcome measure) | ||||
| Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria: - |
||||
| Sex/Gender |
|
||||
| Ages | 18 Years and older (Adult, Older Adult) | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts | Contact information is only displayed when the study is recruiting subjects | ||||
| Listed Location Countries | Not Provided | ||||
| Removed Location Countries | |||||
| Administrative Information | |||||
| NCT Number | NCT03973892 | ||||
| Other Study ID Numbers | 29651771 | ||||
| Has Data Monitoring Committee | No | ||||
| U.S. FDA-regulated Product |
|
||||
| IPD Sharing Statement |
|
||||
| Responsible Party | Fondation Ophtalmologique Adolphe de Rothschild | ||||
| Study Sponsor | Fondation Ophtalmologique Adolphe de Rothschild | ||||
| Collaborators | Not Provided | ||||
| Investigators | Not Provided | ||||
| PRS Account | Fondation Ophtalmologique Adolphe de Rothschild | ||||
| Verification Date | May 2019 | ||||
